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Abstract 
The collaborative, community-based Vaccine 
Ontology (VO) was developed to promote vaccine 
data standardization, integration, and computer-
assisted reasoning. Currently VO covers a variety of 
aspects of the vaccine domain, with an emphasis on 
classification of vaccines and vaccine components, 
and on host immune response to vaccines. VO can be 
used for a number of applications, e.g., ontology-
based vaccine literature mining through 
collaboration with the National Center for 
Integrative Biomedical Informatics (NCIBI).    
Introduction 
Vaccination is the most important invention to 
prevent various diseases and improve public health. 
With extensive vaccine research and clinical usages, 
it has become challenging to standardize vaccine 
annotation, integrate information about varied 
vaccine types, and support computer-assisted 
reasoning. To address this challenge, we developed 
the community-based Vaccine Ontology (VO; 
www.violinet.org/vaccineontology).  
Results of VO development  
As of June 8, 2009, VO contains 1802 classes, 192 
object properties, and 13 datatype properties. Among 
these terms, 934 classes and 19 properties are 
assigned VO-specific IDs. In addition, VO includes 
38 classes from the Basic Formal Ontology (BFO; 
www.ifomis.org/bfo) as upper-level framework, 24 
terms from Relation Ontology (RO), 37 classes from 
Ontology for Biomedical Investigation (OBI), and 
many terms from other ontologies. VO development 
follows the OBO Foundry principles 
(obofoundry.org/crit.shtml).  
VO has defined ‘vaccine’ as a ‘processed material’ 
that is prepared and used to protect against a 
pathogen organism or a disease (e.g., cancer). For 
example, the vaccine Fluvirin has the following 
hierarchical structure by definition: vaccine -> viral 
vaccine -> Influenza virus vaccine -> Fluvirin. More 
than 300 licensed vaccines and vaccine candidates in 
research or clinical trials have been described in VO. 
Vaccine components, vaccination protocols, and host 
responses to vaccination are also major focuses of 
current VO development.  
VO can be used for a number of applications. For 
example, VO dramatically improves PubMed vaccine 
literature searching and is being applied to the 
development of an ontology-based vaccine literature 
mining system through collaboration with NCIBI. 
Vaccine-specific immune networks are being 
investigated using ontology-specific literature mining 
and advanced statistical methods. .  
Discussion  
VO will include all licensed vaccines in different 
countries and regions, as well as all possible vaccines 
in clinical trials and in research for major diseases. 
Planned future development of the VO will add 
further details such as clinical trials of vaccine, 
vaccine surveillance, and safety reports. VO will 
allow advanced integration and intelligent analysis of 
large amounts of worldwide vaccine data.  
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